Octagam (Human Normal Immunoglobulin)

Human Normal Immunoglobulin, the active ingredient in Octagam, is an immunoglobulin presented as a strength/form for intravenous use. It replaces missing antibodies and is used in patients with immune deficiencies and certain autoimmune conditions. GNH USA supplies Octagam as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

GNH USA supplies Octagam as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Octagam is an immunoglobulin therapy that acts on disorders of the immune system.

- Primary immunodeficiency diseases: provides passive immunity to reduce infection frequency. - Chronic inflammatory demyelinating polyneuropathy (CIDP): helps restore nerve function and reduce relapse rates. - Multifocal motor neuropathy (MMN): improves muscle strength and functional ability. - Immune thrombocytopenia (ITP) refractory to other treatments: raises platelet counts. - Kawasaki disease (in children < 5 years): reduces coronary artery complications.

Adverse reactions to Octagam vary in frequency and severity.

Common Side Effects: - Headache - Fever - Chills - Nausea - Fatigue - Mild infusion‑related erythema

Serious or Rare Side Effects: - Anaphylaxis - Acute hemolytic anemia - Thromboembolic events - Renal impairment - Severe aseptic meningitis - Transfusion‑related acute lung injury (TRALI)

Octagam should be used with careful clinical monitoring and adherence to safety guidelines.

- Infusion rate: administer slowly and adjust based on tolerance. - Pre‑medication: consider antihistamines or acetaminacetyl. - Renal function: assess baseline kidney function and monitor during therapy. - Thrombotic risk: evaluate patient history of clotting disorders. - Pregnancy: weigh benefits against potential risks; use only if clearly needed. - Store at 2-8°C: keep refrigerated ; protect from light and do not freeze or shake.

Octagam may interact with several concomitant medicines, requiring vigilance.

Major Interactions (Avoid): - Live‑vaccinated .  - Immunoglobulin‑c  -   Moderate  t  t  t  t

t